Sexual orientation and anabolic-androgenic steroids in US adolescent boys

Aaron J. Blashill, Steven Safren

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

OBJECTIVES: We compared the lifetime prevalence of anabolic-androgenic steroid (AAS) misuse among sexual minority versus heterosexual US adolescent boys, and secondarily, sought to explore possible intermediate variables that may explain prevalence differences. METHODS: Participants were 17 250 adolescent boys taken from a pooled data set of the 14 jurisdictions from the 2005 and 2007 Youth Risk Behavior Surveys that assessed sexual orientation. Data were analyzed for overall prevalence of AAS misuse and possible intermediary risk factors. RESULTS: Sexual minority adolescent boys were at an increased odds of 5.8 (95% confidence interval 4.1-8.2) to report a lifetime prevalence of AAS (21% vs 4%) compared with their heterosexual counterparts, P <.001. Exploratory analyses suggested that increased depressive symptoms/suicidality, victimization, and substance use contributed to this disparity. CONCLUSIONS: This is the first known study to test and find substantial health disparities in the prevalence of AAS misuse as a function of sexual orientation. Prevention and intervention efforts are needed for sexual minority adolescent boys.

Original languageEnglish (US)
Pages (from-to)469-475
Number of pages7
JournalPediatrics
Volume133
Issue number3
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Testosterone Congeners
Sexual Behavior
Heterosexuality
Crime Victims
Risk-Taking
Steroids
Sexual Orientation
Boys
Confidence Intervals
Depression
Health
Sexual Minorities
Sexual
Minorities

Keywords

  • Anabolic-androgenic steroids, adolescents, boys
  • Sexual orientation

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Arts and Humanities (miscellaneous)

Cite this

Sexual orientation and anabolic-androgenic steroids in US adolescent boys. / Blashill, Aaron J.; Safren, Steven.

In: Pediatrics, Vol. 133, No. 3, 2014, p. 469-475.

Research output: Contribution to journalArticle

@article{c235f7a25689434290e19cd1e381370c,
title = "Sexual orientation and anabolic-androgenic steroids in US adolescent boys",
abstract = "OBJECTIVES: We compared the lifetime prevalence of anabolic-androgenic steroid (AAS) misuse among sexual minority versus heterosexual US adolescent boys, and secondarily, sought to explore possible intermediate variables that may explain prevalence differences. METHODS: Participants were 17 250 adolescent boys taken from a pooled data set of the 14 jurisdictions from the 2005 and 2007 Youth Risk Behavior Surveys that assessed sexual orientation. Data were analyzed for overall prevalence of AAS misuse and possible intermediary risk factors. RESULTS: Sexual minority adolescent boys were at an increased odds of 5.8 (95{\%} confidence interval 4.1-8.2) to report a lifetime prevalence of AAS (21{\%} vs 4{\%}) compared with their heterosexual counterparts, P <.001. Exploratory analyses suggested that increased depressive symptoms/suicidality, victimization, and substance use contributed to this disparity. CONCLUSIONS: This is the first known study to test and find substantial health disparities in the prevalence of AAS misuse as a function of sexual orientation. Prevention and intervention efforts are needed for sexual minority adolescent boys.",
keywords = "Anabolic-androgenic steroids, adolescents, boys, Sexual orientation",
author = "Blashill, {Aaron J.} and Steven Safren",
year = "2014",
doi = "10.1542/peds.2013-2768",
language = "English (US)",
volume = "133",
pages = "469--475",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "3",

}

TY - JOUR

T1 - Sexual orientation and anabolic-androgenic steroids in US adolescent boys

AU - Blashill, Aaron J.

AU - Safren, Steven

PY - 2014

Y1 - 2014

N2 - OBJECTIVES: We compared the lifetime prevalence of anabolic-androgenic steroid (AAS) misuse among sexual minority versus heterosexual US adolescent boys, and secondarily, sought to explore possible intermediate variables that may explain prevalence differences. METHODS: Participants were 17 250 adolescent boys taken from a pooled data set of the 14 jurisdictions from the 2005 and 2007 Youth Risk Behavior Surveys that assessed sexual orientation. Data were analyzed for overall prevalence of AAS misuse and possible intermediary risk factors. RESULTS: Sexual minority adolescent boys were at an increased odds of 5.8 (95% confidence interval 4.1-8.2) to report a lifetime prevalence of AAS (21% vs 4%) compared with their heterosexual counterparts, P <.001. Exploratory analyses suggested that increased depressive symptoms/suicidality, victimization, and substance use contributed to this disparity. CONCLUSIONS: This is the first known study to test and find substantial health disparities in the prevalence of AAS misuse as a function of sexual orientation. Prevention and intervention efforts are needed for sexual minority adolescent boys.

AB - OBJECTIVES: We compared the lifetime prevalence of anabolic-androgenic steroid (AAS) misuse among sexual minority versus heterosexual US adolescent boys, and secondarily, sought to explore possible intermediate variables that may explain prevalence differences. METHODS: Participants were 17 250 adolescent boys taken from a pooled data set of the 14 jurisdictions from the 2005 and 2007 Youth Risk Behavior Surveys that assessed sexual orientation. Data were analyzed for overall prevalence of AAS misuse and possible intermediary risk factors. RESULTS: Sexual minority adolescent boys were at an increased odds of 5.8 (95% confidence interval 4.1-8.2) to report a lifetime prevalence of AAS (21% vs 4%) compared with their heterosexual counterparts, P <.001. Exploratory analyses suggested that increased depressive symptoms/suicidality, victimization, and substance use contributed to this disparity. CONCLUSIONS: This is the first known study to test and find substantial health disparities in the prevalence of AAS misuse as a function of sexual orientation. Prevention and intervention efforts are needed for sexual minority adolescent boys.

KW - Anabolic-androgenic steroids, adolescents, boys

KW - Sexual orientation

UR - http://www.scopus.com/inward/record.url?scp=84895150292&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895150292&partnerID=8YFLogxK

U2 - 10.1542/peds.2013-2768

DO - 10.1542/peds.2013-2768

M3 - Article

C2 - 24488735

AN - SCOPUS:84895150292

VL - 133

SP - 469

EP - 475

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 3

ER -